Scheduled to apply for approval of the domestic clinical trial (Phase 1)28%
Intra-venous infusion treatment for diabetic nephropathy
SMUP-IV-01, SMUP allogeneic umbilical cord blood-derived mesenchymal stem cells, is under development for the treatment and prevention of Diabetic Nephropathy. Currently, the non-clinical result of SMUP-IV-01 is developed and obtained for diabetic nephropathy.
Mechanism of Action for SMUP-IV-01